LOS ANGELES, Nov. 29, 2024 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against PACS Group, Inc. ("PACS" or "the Company") (NYSE: PACS) for violations of the federal securities laws.Investors who purchased the Company's securities pursuant and/or traceable to the Company's Offering Documents in connection with its initial public offering ("IPO") conducted on April 11, 2024, or between April 11, 2024 and November 5, 2024, i ...

NEW YORK, Nov. 28, 2024 (GLOBE NEWSWIRE) -- Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead t ...

NEW ORLEANS, Nov. 27, 2024 (GLOBE NEWSWIRE) -- ClaimsFiler, a FREE shareholder information service, reminds investors that they have until January 13, 2025 to file lead plaintiff applications in securities class action lawsuits against PACS Group, Inc. (NYSE: PACS), if they purchased or otherwise acquired the Company’s a) securities between April 11, 2024 and November 5, 2024 inclusive (the “Class Period”), and/or b) shares pursuant and/or traceable to the registration statement and prospectus (collectively ...

RADNOR, Pa., Nov. 27, 2024 /PRNewswire/ -- The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against PACS Group, Inc. ("PACS") (NYSE: PACS). The lawsuit is brought on behalf of investors who purchased or otherwise acquired PACS: 1) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the "Registration Statement") issued in connection with PACS' April 11, 2024 initial public o ...

Lexington, MA, Nov. 27, 2024 (GLOBE NEWSWIRE) --  FUJIFILM Healthcare Americas Corporation,  a leading provider of diagnostic and enterprise imaging solutions, will demonstrate its growing Synapse® Enterprise Imaging portfolio at booth #4100 at the 2024 Radiological Society of North America (RSNA) Conference and Annual meeting held December 1-5. Fujifilm will be highlighting a few of the company’s latest advancements with RSNA attendees, including the Synapse Viewer eXtension (VX), an elective, native PACS ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of PACS Group Inc. (NYSE: PACS) of (i) common stock pursuant and/or traceable to the registration statement and prospectus (collectively, the “Registration Statement”) in connection with the Company’s April 11, 2024 initial public offering ("IPO"); (ii) securities between April 11, 2024 and November 5, 2024, both dates inclusive (the “Class Period”); and/or (iii) common stock pursuant and/ ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of PACS Group, Inc. (NYSE: PACS). Shareholders who purchased shares of PACS during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/pacs-group-inc-loss-submission-form/?id=113437&from=3  CLASS PERIOD: This lawsuit i ...

NEW YORK, Nov. 26, 2024 (GLOBE NEWSWIRE) --  Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against PACS Group, Inc. (NYSE: PACS) and certain of the Company’s senior executives for potential violations of the federal securities laws. If you invested in PACS, you are encouraged to obtain additional information by visiting: https://www.bfalaw.com/cases-investigations/pacs-group-inc. Investors have until January 13, 2025, to ask the Court to be appointed to lead ...

NEW ORLEANS, Nov. 22, 2024 /PRNewswire/ -- Kahn Swick & Foti, LLC ("KSF") and KSF partner, former Attorney General of Louisiana, Charles C. Foti, Jr., remind investors that they have until January 13, 2025 to file lead plaintiff applications in securities class action lawsuits against PACS Group, Inc. (NYSE: PACS), if they purchased or otherwise acquired the Company's a) securities between April 11, 2024 and November 5, 2024 inclusive (the "Class Period"), and/or b) shares pursuant and/or traceable to the r ...

文章核心观点 - PACS Group及其部分高管被列为被告，面临证券集体诉讼，指控其违反美国证券法 [1][2] - 诉讼指控PACS在IPO文件和整个诉讼期间发布虚假和误导性声明，未披露其参与的欺诈行为 [2] - Hindenburg的报告揭示了PACS的业务模式依赖于滥用纳税人资助的医疗保健计划 [3] - 报告发布后，PACS股价大幅下跌，公司推迟了第三季度财报发布 [4][5] 诉讼详情 - 集体诉讼期间：2024年4月11日至2024年11月5日 [2] - 主要原告截止日期：2025年1月13日 [2] - 诉讼指控PACS参与的欺诈行为包括提交虚假Medicare索赔、对Medicare计费数千次不必要的呼吸和感觉统合疗法、伪造与许可和人员配置相关的文件 [2] Hindenburg报告 - Hindenburg的报告是经过五个月调查的结果，涉及与多名前员工和竞争对手的访谈 [3] - 报告指控PACS滥用COVID时期的豁免权，不当访问数千名患者的Medicare福利 [3] - 报告还指控PACS伪造患者记录以夸大收入和盈利，并参与欺诈性许可实践以规避监管监督 [3] 市场反应 - Hindenburg报告发布后，PACS股价下跌11.93美元，跌幅超过27% [4] - 2024年11月6日，PACS宣布收到联邦政府的民事调查要求，涉及公司的报销和转诊实践，可能与第三方报告有关，并推迟了第三季度财报发布 [4] - 这一消息导致PACS股价进一步下跌11.45美元，跌幅超过38%，收盘价为18.09美元，远低于21美元的IPO价格 [5] 法律行动 - Hagens Berman律师事务所已对PACS的业务实践和披露进行调查，寻求代表因公司涉嫌不当行为而遭受重大损失的投资者 [5][6] - 调查重点是PACS是否误导了投资者和监管机构关于其业务实践和价值创造策略 [6] - 律师事务所鼓励拥有非公开信息的个人考虑参与调查或利用SEC举报人计划 [7] 关于Hagens Berman - Hagens Berman是一家全球原告权利复杂诉讼公司，专注于企业问责 [8] - 该公司的团队在此领域已获得超过29亿美元的成功 [9]